Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial

BACKGROUND: Active surveillance has been proposed for patients with oesophageal cancer in whom there is a complete clinical response after neoadjuvant chemoradiotherapy (nCRT). However, endoscopic biopsies have limited negative predictive value in detecting residual disease. This study determined th...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Surg
Asıl Yazarlar: van der Wilk, B. J., Eyck, B. M., Doukas, M., Spaander, M. C. W., Schoon, E. J., Krishnadath, K. K., Oostenbrug, L. E., Lagarde, S. M., Wijnhoven, B. P. L., Looijenga, L. H. J., Biermann, K., van Lanschot, J. J. B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd. 2020
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689829/
https://ncbi.nlm.nih.gov/pubmed/32757307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bjs.11760
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller